Loading...
Tolvaptan corrects hyponatremia and relieves the burden of fluid/dietary restriction and hospitalization in hyponatremic patients with terminal lung cancer: a report of two cases
Case 1: A 45-year-old man, admitted for symptomatic hyponatremia, was diagnosed with advanced small-cell lung cancer and severe hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone. In addition to chemotherapy, the patient was treated with increased dietary salt intake...
Saved in:
| Published in: | CEN Case Rep |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer Singapore
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6450990/ https://ncbi.nlm.nih.gov/pubmed/30637666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-019-00375-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|